Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document reports a completed Phase 1/2 clinical trial evaluating a vaccine therapy plus interleukin-2 in women with advanced breast or ovarian cancer. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Vaccine therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED